Implantable Device for Male Reproductive Sterilization
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study is to evaluate a device for male reproductive sterilization and determine if this device is successful at blocking the sperm.
Ninety subjects from two centers in the United Stated will be followed closely for 24 months.
If you are someone interested in a vasectomy, you may be eligible to participate in this clinical study.
| Condition | Intervention | Phase |
|---|---|---|
|
Male Sterilization |
Device: Intra Vas Device (IVD) |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | The Intra Vas Device (IVD) As A Means of Male Reproductive Sterilization A Single Armed Feasibility Study |
- Successful IVD implantation with vas deferens occlusion at 6 and 24 months post-implant.
- The IVD consists of a tubular silicone plug that is inserted into the lumen of the vas deferens to block the flow of semen.
- IVD implantation does not require the need to sever or permanently damage the vas deferens like the Ligation/Excision, Clip devices, Cautery
- techniques or Fascial Interposition require. One major advantage of the IVD is that it
- does not require excision and removal of a portion of the vas. Implantation of the IVD
- allows the vas deferens to remain intact and not be permanently damaged.
| Estimated Enrollment: | 90 |
| Study Start Date: | September 2006 |
| Estimated Study Completion Date: | September 2009 |
This feasibility study is intended to collect pertinent clinical information on the use of the Shepherd Medical Intra Vas Device (IVD) necessary to support the design of a future pivotal study. The IVD is intended to occlude the vas deferens and thus accomplish male reproductive sterilization and to offer an additional method to vasectomy.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Subject desires to undergo a vasectomy.
- Freely consents to participate in the Study a
- Agrees to provide a semen sample at regularized periods for at least 30 months.
- Willing to use a redundant method of contraception until successful occlusion is confirmed.
- Agrees to provide follow-up information.
- Willing and able to understand and agree to follow all aspects of the procedures and Study requirements.
- At least 18 years of age.
Exclusion Criteria:
- Has a condition permanently or temporarily making participation in the Study inadvisable.
- Has a condition permanently or temporarily making a vasectomy inadvisable.
- Has had a previous successful/unsuccessful vasectomy.
- Has had an allergic reaction to silicone and/or ethylene.
Contacts and Locations| United States, Florida | |
| Douglas G. Stein, MD, PA | |
| Tampa, Florida, United States, 33613 | |
| United States, Louisiana | |
| Regional Urology, LLC | |
| Shreveport, Louisiana, United States, 71106 | |
| United States, Minnesota | |
| Adult and Pediatric Urology | |
| Sartell, Minnesota, United States, 56377 | |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00335361 History of Changes |
| Other Study ID Numbers: | G050215, NIH grant # R44HD046318 |
| Study First Received: | June 7, 2006 |
| Last Updated: | April 5, 2007 |
| Health Authority: | United States: Food and Drug Administration |
Keywords provided by Shepherd Medical Company:
|
Male Contraceptive Devices Intra Vas Device (IVD) Male Sterilization |
Vasectomy Intra Vas Deferens Occlusion Vas Occlusion |
Additional relevant MeSH terms:
|
Disinfectants Anti-Infective Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 19, 2013